What’s Next: Innovation, Investment, Impact
In a market defined by capital discipline, regulatory scrutiny, and scientific risk, clarity matters.
In 2026, progress demands disciplined innovation, strategic investment, and measurable impact.
Fierce Biotech Week brings leaders across R&D, Clinical & TMF, BD&L, and PR & Communications together to align strategy and determine what moves forward.
Fierce Biotech Week By The Numbers:
Be in the Room Where Decisions Are Made
Fierce Biotech Week attracts senior leaders across biotech and pharma, including:
C-suite executives and founders
Heads of R&D and Drug Development
Clinical & TMF leadership
BD&L and corporate strategy teams
PR & Communications executives
Strategic outsourcing partners
This is not a spectator audience. It’s a room of decision-makers.
THE FIERCE DIFFERENCe
Curated Connections - Thoughtfully designed networking for meaningful business relationships.
Content That Matters - Real industry challenges. Actionable insights. Substance over hype.
Dealmaking by Design - 1:1 meetings, curated networking, and connections built for business.
The Drug
Development Lifecycle,
Under One Roof
Where decision-makers align.
Drug Development
Advance pipelines in a capital-disciplined market. Explore modality convergence, AI integration, manufacturing readiness, and portfolio strategy.
Clinical & TMF
Drive operational excellence under regulatory pressure. Navigate global divergence, inspection readiness, and execution risk.
BD&L
Structure smarter partnerships and evaluate pipeline value in a constrained capital environment.
PR & Communications
Align corporate narrative with science, milestones, and market volatility to protect valuation and reputation.
